TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton cont...

FDA Recall #D-219-2013 — Class III — November 26, 2012

Recall #D-219-2013 Date: November 26, 2012 Classification: Class III Status: Terminated

Product Description

TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01

Reason for Recall

Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.

Recalling Firm

Pfizer Inc. — New York, NY

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

10920 kits

Distribution

Nationwide

Code Information

Lots P00025A; P00027B

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated